These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 31446518)

  • 21. Specific antibody-mediated immunity in the reproductive tract of laying chickens immunized against Newcastle disease with conventional attenuated and inactivated vaccines.
    Rauw F; Nguyen TG; Ngabirano E; Marché S; Lambrecht B
    Avian Pathol; 2017 Aug; 46(4):434-441. PubMed ID: 28290220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination with Newcastle disease vaccine and CpG oligodeoxynucleotides induces specific immunity and protection against Newcastle disease virus in SPF chicken.
    Linghua Z; Xingshan T; Fengzhen Z
    Vet Immunol Immunopathol; 2007 Feb; 115(3-4):216-22. PubMed ID: 17157392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of Toll-like receptor agonists on the immunogenicity of MVA-SARS-2-S vaccine after intranasal administration in mice.
    Do KTH; Willenzon S; Ristenpart J; Janssen A; Volz A; Sutter G; Förster R; Bošnjak B
    Front Cell Infect Microbiol; 2023; 13():1259822. PubMed ID: 37854858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant effects of chicken interleukin-18 in avian Newcastle disease vaccine.
    Hung LH; Li HP; Lien YY; Wu ML; Chaung HC
    Vaccine; 2010 Feb; 28(5):1148-55. PubMed ID: 19948265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and protective efficacy of an inactivated Newcastle disease virus vaccine encapsulated in poly-(lactic-co-glycolic acid) nanoparticles.
    Ananda Kumar BS; Panickan S; Bindu S; Kumar V; Ramakrishnan S; Saxena S; Shrivastava S; Dandapat S
    Poult Sci; 2023 Jun; 102(6):102679. PubMed ID: 37116285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza.
    Zhao J; Yang H; Xu H; Ma Z; Zhang G
    Virol J; 2017 Mar; 14(1):56. PubMed ID: 28302119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant NDV expressing cytokines or fliC confers a quick immune response against NDV challenge and resistance to maternal antibody.
    Zhang T; Liu Y; Wang H; Zhang X; Zhu S; Xu P; Yin J; Ren G; Liu J; Li D
    Vet Microbiol; 2016 Nov; 196():107-117. PubMed ID: 27939146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diatoms and diatomaceous earth as novel poultry vaccine adjuvants.
    Nazmi A; Hauck R; Davis A; Hildebrand M; Corbeil LB; Gallardo RA
    Poult Sci; 2017 Feb; 96(2):288-294. PubMed ID: 27433013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TLR8 combined withTLR3 or TLR4 agonists enhances DC-NK driven effector Tc1 cells.
    Nouri-Shirazi M; Tamjidi S; Nourishirazi E; Guinet E
    Immunol Lett; 2018 Jan; 193():58-66. PubMed ID: 29103998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of a novel DNA vaccine candidate targeting F gene of genotype VII Newcastle disease virus and chicken IL-18 delivered by Salmonella.
    Gao X; Xu K; Yang G; Shi C; Huang H; Wang J; Yang W; Liu J; Liu Q; Kang Y; Jiang Y; Wang C
    J Appl Microbiol; 2019 May; 126(5):1362-1372. PubMed ID: 30785663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study on immune efficacy of Newcastle disease chitosan microsphere vaccine].
    Zhai RL; Xu HY; Wang YL; Qin ZM; Jiang SJ
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):692-6. PubMed ID: 17944374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethanol, TLR3, and TLR4 Agonists Have Unique Innate Immune Responses in Neuron-Like SH-SY5Y and Microglia-Like BV2.
    Lawrimore CJ; Crews FT
    Alcohol Clin Exp Res; 2017 May; 41(5):939-954. PubMed ID: 28273337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation and evaluation of a recombinant Newcastle disease virus strain R2B with an altered fusion protein cleavage site as a vaccine candidate.
    Yadav K; Pathak DC; Saikia DP; Debnath A; Ramakrishnan S; Dey S; Chellappa MM
    Microb Pathog; 2018 May; 118():230-237. PubMed ID: 29578068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic effects of adjuvants interferon-gamma and levamisole on DNA vaccination against infection with Newcastle disease virus.
    Yin J; Jin H; Yang F; Ding Z; Huang C; Zhu Q; Wang B
    Viral Immunol; 2007; 20(2):288-99. PubMed ID: 17603845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge.
    Miller PJ; King DJ; Afonso CL; Suarez DL
    Vaccine; 2007 Oct; 25(41):7238-46. PubMed ID: 17719150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Chicken Interferon Gamma on Newcastle Disease Virus Vaccine Immunogenicity.
    Cardenas-Garcia S; Dunwoody RP; Marcano V; Diel DG; Williams RJ; Gogal RM; Brown CC; Miller PJ; Afonso CL
    PLoS One; 2016; 11(7):e0159153. PubMed ID: 27409587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The positive adjuvant effect of chitosan on antigen-specific cell-mediated immunity after chickens vaccination with live Newcastle disease vaccine.
    Rauw F; Gardin Y; Palya V; Anbari S; Gonze M; Lemaire S; van den Berg T; Lambrecht B
    Vet Immunol Immunopathol; 2010 Apr; 134(3-4):249-58. PubMed ID: 19939464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A bacterial ghost improves the immunological efficacy of a Newcastle disease virus inactivated vaccine.
    Si W; Yu S; Liu H; Wang C; Chen L; Wang G; Wu J; Liu S
    Vet Microbiol; 2017 May; 203():189-195. PubMed ID: 28619143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a novel Newcastle disease virus (NDV) neutralization test based on recombinant NDV expressing enhanced green fluorescent protein.
    Chumbe A; Izquierdo-Lara R; Calderón K; Fernández-Díaz M; Vakharia VN
    Virol J; 2017 Nov; 14(1):232. PubMed ID: 29169354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigenic variation of LaSota and genotype VII Newcastle disease virus (NDV) and their efficacy against challenge with velogenic NDV.
    Yang HM; Zhao J; Xue J; Yang YL; Zhang GZ
    Vaccine; 2017 Jan; 35(1):27-32. PubMed ID: 27889255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.